Back
Citizens Financial Services Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
27
CZFS
Citizens Financial Services
Last Price:
$54.70
Seasonality Move:
-0.8%
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
$49.71
Seasonality Move:
12.51%
Sell
27
Citizens Financial Services (CZFS)
is a Sell
Is Citizens Financial Services a Buy, Sell or Hold?
-
The current Citizens Financial Services [CZFS] share price is $55.37. The Score for CZFS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CZFS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $50.31. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CZFS Stock Price Chart
What is Citizens Financial Services's stock price today?
-
The Citizens Financial Services share price today is $55.37The current trend is moderately bullish and CZFS is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $50.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
CZFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.23 | Buy |
| Relative Strength Index (14 RSI): | 44.23 | Sell |
| Chaikin Money Flow: | 3063 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.72 - 59.18) | Sell |
| Bollinger Bands (100): | (57.77 - 67.99) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.43 | Sell |
| Relative Strength Index (14 RSI): | 25.41 | Sell |
| Chaikin Money Flow: | -2337291 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.24 - 93.24) | Sell |
| Bollinger Bands (100): | (85.21 - 128.11) | Sell |
CZFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56 | Sell |
| 20-day SMA: | 57.51 | Sell |
| 50-day SMA: | 59.55 | Sell |
| 200-day SMA: | 57.82 | Sell |
| 8-day EMA: | 55.06 | Buy |
| 20-day EMA: | 45.27 | Buy |
| 50-day EMA: | 26.97 | Buy |
| 200-day EMA: | 8.46 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.64 | Sell |
| 20-day SMA: | 68.68 | Sell |
| 50-day SMA: | 92.51 | Sell |
| 200-day SMA: | 121.01 | Sell |
| 8-day EMA: | 56.28 | Sell |
| 20-day EMA: | 67.87 | Sell |
| 50-day EMA: | 86.24 | Sell |
| 200-day EMA: | 111.03 | Sell |
Citizens Financial Services Earnings Growth & CZFS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.03 per share, an increase this year of $1.09 per share, and an increase next year of $0.35 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.35 per share, a decrease next quarter of $0.47 per share, an increase this year of $4.58 per share, and an increase next year of $5.49 per share.
Citizens Financial Services Technical Analysis
| Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||